Value of SATB2 Immunostaining in the Distinction between Small Intestinal and Colorectal Adenocarcinomas

被引：0
|
作者：
Kim, C. J.
Baruch-Oren, T.
Lin, F.
Fan, X.
Yang, X. J.
Wang, H. L.
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Geisinger Med Ctr, Danville, PA 17822 USA
[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[4] Northwestern Univ, Chicago, IL 60611 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
749
引用
收藏
页码：184A / 184A
页数：1
相关论文
共 50 条
  • [41] Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer
    Wang, Shuang
    Zhou, Jun
    Wang, Xiao-Yan
    Hao, Jun-Mei
    Chen, Juan-Zhi
    Zhang, Xiang-Mei
    Jin, He
    Liu, Li
    Zhang, Yan-Fei
    Liu, Jinsong
    Ding, Yan-Qing
    Li, Jian-Ming
    JOURNAL OF PATHOLOGY, 2009, 219 (01): : 114 - 122
  • [42] LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2
    Xu, Mu
    Xu, Xueni
    Pan, Bei
    Chen, Xiaoxiang
    Lin, Kang
    Zeng, Kaixuan
    Liu, Xiangxiang
    Xu, Tao
    Qin, Jian
    He, Bangshun
    Pan, Yuqin
    Sun, Huiling
    Wang, Shukui
    MOLECULAR CANCER, 2019, 18 (01)
  • [43] IBD associated colorectal carcinomas are frequently associated with loss of SATB2 expression and an aberrant mucin
    Iwaya, Mai
    Ota, Hiroyoshi
    Tateishi, Yoko
    Nakajima, Tomoyuki
    Riddell, Robert
    Conner, James
    MODERN PATHOLOGY, 2018, 31 : 270 - 271
  • [44] Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20
    Lee, Ji Ae
    Seo, Mi-Kyoung
    Yoo, Seung-Yeon
    Cho, Nam-Yun
    Kwak, Yoonjin
    Lee, Kyoungbun
    Kim, Jung Ho
    Kang, Gyeong Hoon
    VIRCHOWS ARCHIV, 2022, 480 (03) : 543 - 555
  • [45] Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20
    Ji Ae Lee
    Mi-Kyoung Seo
    Seung-Yeon Yoo
    Nam-Yun Cho
    Yoonjin Kwak
    Kyoungbun Lee
    Jung Ho Kim
    Gyeong Hoon Kang
    Virchows Archiv, 2022, 480 : 543 - 555
  • [46] miR-3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2
    Yang, Daqing
    Li, Rizeng
    Xia, Jianfu
    Li, Wencai
    Zhou, Hong
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 4847 - 4854
  • [47] Overexpression of miR-599 is associated with metastasis in colorectal cancer via inhibition of SATB2
    Gu, Jing-Feng
    Wang, Gui-Qi
    Gao, Ying-Chao
    Dai, Yong-Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (06): : 6701 - 6709
  • [48] Diagnostic accuracy of SATB2 in identifying primary and metastatic colorectal carcinoma: a comparative immunohistochemical study
    Elnady, Manar S.
    Eltatawy, Faika A.
    Nosseir, Azima G.
    Zamzam, Yomna A.
    El-Guindy, Dina M.
    ECANCERMEDICALSCIENCE, 2022, 16
  • [49] Hep Par 1 expression in small intestinal and colorectal epithelium and adenocarcinomas
    Mac, M. T.
    Chung, F.
    Lin, F.
    Hui, P.
    Balzer, B. L.
    Wang, H. L.
    MODERN PATHOLOGY, 2008, 21 : 128A - 128A
  • [50] Hep par 1 expression in small intestinal and colorectal epithelium and adenocarcinomas
    Mac, M. T.
    Chung, F.
    Liu, F.
    Hui, P.
    Balzer, B. L.
    Wang, H. L.
    LABORATORY INVESTIGATION, 2008, 88 : 128A - 128A
12345